Another recently has highlighted differential expression patterns of Msi-2 isoforms in triple-negative breast cancer (TNBC) and has demonstrated that downregulation of a predominant isoform (Msi-2a) is associated with TNBC progression [30]. The gene discussed is MSI2; the disease is triple-negative breast carcinoma.